about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
4.34
-0.14
(-3.12%)
16,697.9
XNAS Volume
XNAS 17 Jul, 2026 1:48 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..